InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Biofrontera Inc.

BFRI Clue Score42
United States Fiscal year ends December CIK 0001858685
$0.97 +5.57% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.97 −78.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Oct 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue18.8Operating income−9.6Net income−11.0Fiscal year 2021Revenue24.1 +27.9%Operating income−25.2Net income−37.7Fiscal year 2022Revenue28.7 +19.0%Operating income−18.6Net income−0.6EPS, diluted−0.61Fiscal year 2023Revenue34.1 +18.8%Operating income−22.7Net income−20.1EPS, diluted−13.02Fiscal year 2024Revenue37.3 +9.5%Operating income−17.2Net income−17.8EPS, diluted−3.22Fiscal year 2025Revenue41.7 +11.7%Operating income−11.3Net income−10.5EPS, diluted−1.04
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 18.8 24.1 28.7 34.1 37.3 41.7
Growth +27.9% +19.0% +18.8% +9.5% +11.7%
Operating income −9.6 −25.2 −18.6 −22.7 −17.2 −11.3
Net income −11.0 −37.7 −0.6 −20.1 −17.8 −10.5
Growth
EPS, diluted n/a n/a −0.61 −13.02 −3.22 −1.04

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Operating margin−51.0%Net margin−58.3%Fiscal year 2021Operating margin−104.6%Net margin−156.5%Fiscal year 2022Operating margin−64.8%Net margin−2.2%Free cash flow margin−56.6%Fiscal year 2023Operating margin−66.6%Net margin−59.1%Free cash flow margin−73.1%Fiscal year 2024Operating margin−46.1%Net margin−47.6%Free cash flow margin−27.5%Fiscal year 2025Operating margin−27.2%Net margin−25.3%Free cash flow margin−32.0%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −51.0% −104.6% −64.8% −66.6% −46.1% −27.2%
Net margin −58.3% −156.5% −2.2% −59.1% −47.6% −25.3%
Free cash flow margin n/a n/a −56.6% −73.1% −27.5% −32.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−12.4Fiscal year 2021Operating cash flow−26.7Fiscal year 2022Operating cash flow−16.2Capital expenditure−0.0Free cash flow−16.2Fiscal year 2023Operating cash flow−24.9Capital expenditure−0.0Free cash flow−24.9Fiscal year 2024Operating cash flow−10.3Capital expenditure−0.0Free cash flow−10.3Fiscal year 2025Operating cash flow−13.4Capital expenditure−0.0Free cash flow−13.4
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −12.4 −26.7 −16.2 −24.9 −10.3 −13.4
Capital expenditure n/a n/a −0.0 −0.0 −0.0 −0.0
Free cash flow n/a n/a −16.2 −24.9 −10.3 −13.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash8.1Shareholders’ equity5.8Fiscal year 2021Cash24.5Shareholders’ equity11.3Fiscal year 2022Cash17.2Shareholders’ equity23.9Fiscal year 2023Cash1.3Shareholders’ equity4.8Fiscal year 2024Cash5.9Shareholders’ equity4.4Fiscal year 2025Cash6.4Shareholders’ equity10.5
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.1 24.5 17.2 1.3 5.9 6.4
Shareholders’ equity 5.8 11.3 23.9 4.8 4.4 10.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
18.8 24.1 28.7 34.1 37.3 41.7
Growth +27.9% +19.0% +18.8% +9.5% +11.7%
n/a n/a n/a 0.1 2.1 3.7
17.7 36.5 35.1 39.0 33.8 37.8
−9.6 −25.2 −18.6 −22.7 −17.2 −11.3
Growth
−10.9 −37.7 −0.6 −20.1 −17.7 −10.5
0.1 0.1 0.0 0.0 0.0 0.0
−11.0 −37.7 −0.6 −20.1 −17.8 −10.5
Growth
Per share
n/a −4.28 −0.61 −13.02 −3.22 −1.04
n/a n/a −0.61 −13.02 −3.22 −1.04
Growth
n/a 8.8 1.1 1.5 5.5 10.2
n/a n/a 1.1 1.5 5.5 10.2
Growth +46.3% +256.7% +84.4%

† The diluted share count jumps at 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 17.2% a year over five years.
  • Operating margin is up 23.8 points on five years ago, at -27.2%.
  • A net loss in 6 of 6 years on file.